UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$25.3B |
| 2 |
Bank of America
BAC
|
+$1.96B |
| 3 |
Applied Materials
AMAT
|
+$1.43B |
| 4 |
NetEase
NTES
|
+$1.18B |
| 5 |
Union Pacific
UNP
|
+$870M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.17B |
| 2 |
Apple
AAPL
|
+$3.39B |
| 3 |
UBS Group
UBS
|
+$2.73B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.53B |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.88% |
| 2 | Financials | 12.37% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.66% |
| 5 | Communication Services | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1501
Welltower
WELL
$169B
| $3.76M | ﹤0.01% |
21,095
-9,672,048
| -100% | -$1.59B |
2013 Q2
49 quarters
|
|
1502
RXO
RXO
$4.72B
| $3.75M | ﹤0.01% |
243,826
-146,763
| -38% | -$2.37M |
2022 Q4
11 quarters
|
|
1503
Benchmark Electronics
BHE
$2.54B
| $3.75M | ﹤0.01% |
97,262
-46,930
| -33% | -$1.86M |
2013 Q2
49 quarters
|
|
1504
LiveRamp
RAMP
$2.28B
| $3.74M | ﹤0.01% |
137,806
-118,989
| -46% | -$3.51M |
2018 Q4
27 quarters
|
|
1505
Equinox Gold
EQX
$13B
| $3.73M | ﹤0.01% |
332,040
-377,652
| -53% | -$3M |
2024 Q2
5 quarters
|
|
1506
DELISTED
Clearway Energy Class A
CWEN.A
| $3.72M | ﹤0.01% |
138,229
-80,160
| -37% | -$2.29M |
2019 Q1
26 quarters
|
|
1507
Tarsus Pharmaceuticals
TARS
$3.19B
| $3.72M | ﹤0.01% |
62,603
-23,775
| -28% | -$1.17M |
2024 Q1
6 quarters
|
|
1508
Adient
ADNT
$1.38B
| $3.72M | ﹤0.01% |
154,326
-103,670
| -40% | -$2.42M |
2016 Q4
35 quarters
|
|
1509
Omnicell
OMCL
$1.61B
| $3.7M | ﹤0.01% |
121,455
-95,349
| -44% | -$2.93M |
2013 Q4
47 quarters
|
|
1510
C3.ai
AI
$1.82B
| $3.69M | ﹤0.01% |
212,673
-146,072
| -41% | -$3.05M |
2020 Q4
19 quarters
|
|
1511
Kinetik
KNTK
$4.45B
| $3.69M | ﹤0.01% |
86,264
-53,088
| -38% | -$2.24M |
2022 Q2
13 quarters
|
|
1512
SM Energy
SM
$9.4B
| $3.68M | ﹤0.01% |
147,532
-136,547
| -48% | -$3.68M |
2013 Q2
49 quarters
|
|
1513
Gulfport Energy Corp
GPOR
$2.94B
| $3.68M | ﹤0.01% |
20,340
-54,870
| -73% | -$9.6M |
2021 Q4
15 quarters
|
|
1514
First Commonwealth Financial
FCF
$2.06B
| $3.6M | ﹤0.01% |
211,250
-118,097
| -36% | -$2.02M |
2013 Q2
49 quarters
|
|
1515
iShares Core S&P Mid-Cap ETF
IJH
$121B
| $3.59M | ﹤0.01% |
54,995
-56,440
| -51% | -$3.63M |
2025 Q1
2 quarters
|
|
1516
Pilgrim's Pride
PPC
$7.01B
| $3.58M | ﹤0.01% |
88,019
-70,584
| -45% | -$3.2M |
2018 Q4
27 quarters
|
|
1517
Energizer
ENR
$1.49B
| $3.58M | ﹤0.01% |
143,917
-92,171
| -39% | -$2.41M |
2015 Q3
40 quarters
|
|
1518
Artivion
AORT
$1.06B
| $3.58M | ﹤0.01% |
84,567
-234,399
| -73% | -$8.83M |
2016 Q4
35 quarters
|
|
1519
Mobileye
MBLY
$6.14B
| $3.58M | ﹤0.01% |
253,544
+10,190
| +4% | +$152K |
2025 Q1
2 quarters
|
|
1520
Goosehead Insurance
GSHD
$1.1B
| $3.56M | ﹤0.01% |
47,853
-33,678
| -41% | -$2.97M |
2020 Q2
21 quarters
|
|
1521
Cohen & Steers
CNS
$3.58B
| $3.56M | ﹤0.01% |
54,233
-38,018
| -41% | -$2.79M |
2017 Q1
34 quarters
|
|
1522
DELISTED
89bio
ETNB
| $3.54M | ﹤0.01% |
241,011
-150,399
| -38% | -$1.53M |
2023 Q3
8 quarters
|
|
1523
TriMas Corp
TRS
$1.39B
| $3.52M | ﹤0.01% |
91,206
-34,323
| -27% | -$1.22M |
2013 Q2
49 quarters
|
|
1524
NETSCOUT
NTCT
$2.77B
| $3.52M | ﹤0.01% |
136,307
-143,383
| -51% | -$3.39M |
2013 Q2
49 quarters
|
|
1525
Hillman Solutions
HLMN
$1.43B
| $3.52M | ﹤0.01% |
383,134
-255,418
| -40% | -$2.31M |
2021 Q4
15 quarters
|
|
Similar funds
UBS AM's Q3 2025 Portfolio in Review
As of Q3 2025, UBS AM held 2,672 positions worth $461B, down 6.8% from $494B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
UBS AM withdrew a net $68.7B in Q3 2025, closing 403 positions and reducing 2,008 holdings. Its most notable exit was Pinduoduo, an estimated $967M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Vanguard Dividend Appreciation ETF worth $135M.
- UBS AM's largest Q3 2025 buy was Vanguard Dividend Appreciation ETF: 624,303 shares worth $135M.
- UBS AM added most to Microsoft in Q3 2025, an estimated $25.3B increase.
- UBS AM's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $7.17B.
- UBS AM fully exited Pinduoduo in Q3 2025, selling an estimated $967M.
- UBS AM's ten largest holdings make up 35% of its $461B portfolio in Q3 2025.
- UBS AM opened 67 new positions and closed 403 in Q3 2025.
- UBS AM's portfolio value fell 6.8% quarter-over-quarter to $461B.
Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.